A 200% tariff rate — even with a delay — will have a detrimental effect on drug prices and profit margins, analysts warn.

Although ‘lean type 2 diabetes’ is not uncommon, clinicians must first exclude other causes including autoimmune, monogenic, ...

Eli Lilly reported impressive data at the recent American Diabetes Association ('ADA') conference. Its robust pipeline will ...

LLY has slid 15.7% over the past year, but surging demand for Mounjaro and Zepbound could revive the stock's momentum.

The drugmaker has become a clear winner with its weight-loss drugs. Now, with a pill under development, the company should see earnings gains through the end of the decade.

Approval was based on results from the Phase IIIb TRAILBLAZER-ALZ 6 trial, which showed that Kisunla achieved comparable ...

Along with announcing a 50% tariff on copper imports, The POTUS threatened to levy tariffs as high as 200% on pharmaceutical ...

Obesity medications, once facing shortages, are now widely available. So how do consumers not get scammed into purchasing ...

Caitlin Clark Makes Exciting Announcement on Thursday originally appeared on Athlon Sports. Indiana Fever point guard Caitlin ...

ASX health stocks fall o.92% over past five days as US President Donald Trump renews threat to impose tariffs on pharmaceutical imports.

Selection Follows Robust Succession Process Led by the Board – – Bruce Cozadd to Retire as CEO and Remain Chairperson of the Board of Directors – ...

In the first placebo-controlled study of vaporized cannabis for acute migraine, patients report greater relief from pain and ...